Kala Bio is a biopharmaceutical company transitioning toward artificial intelligence infrastructure for the biotechnology and pharmaceutical sectors. The company develops and deploys the Researgency AI platform, a dedicated, on-premises AI-as-a-service solution designed to enable biotech and pharmaceutical companies to harness advanced artificial intelligence capabilities—including autonomous workflow orchestration and private large language model deployment—while maintaining complete control over proprietary data and meeting stringent regulatory compliance requirements such as HIPAA and GDPR. The company targets mid-size biotechnology firms, contract research organizations, pharmaceutical companies, and academic institutions, generating revenue through platform licensing and deployment services that address critical operational challenges in drug development including clinical trial analysis, regulatory submission support, and secure data governance.